For the quarter ending 2026-03-31, TVTX had -$14,673K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss from continuing operations | -36,602 | -21,986 | 25,706 | -53,981 |
| Foreign currency remeasurement impact | - | - | 301 | 2,165 |
| Depreciation and amortization | 25,212 | 18,137 | 15,788 | 26,818 |
| Share based compensation | 16,146 | 11,464 | 11,263 | 22,141 |
| In-process research and development | - | 0 | 0 | 0 |
| Loss on allowance for inventory | - | 684 | - | - |
| Amortization of debt discount and issuance costs | - | 1,640 | - | - |
| Amortization of discounts on investments | - | 4,436 | - | - |
| Other | 4 | -43 | 807 | 693 |
| Accounts receivable | 7,225 | -27,819 | 44,155 | 11,486 |
| Inventory | 742 | -1,177 | -194 | -3,645 |
| Income taxes | - | -849 | - | - |
| Prepaid expenses and other current and non-current assets | 6,382 | -446 | 1,327 | 6,777 |
| Change in lease assets and liabilities, net | - | -622 | - | - |
| Accounts payable | -11,809 | 6,247 | -1,109 | -5,223 |
| Accrued expenses | -20,900 | 17,339 | 19,701 | -8,200 |
| Deferred revenue | 0 | 0 | 0 | -2,815 |
| Other current and non-current liabilities | 1,940 | -589 | -10,636 | 1,525 |
| Net cash provided by (used in) operating activities - continuing operations | - | 60,678 | 14,317 | -37,211 |
| Net cash (used in) provided by operating activities - discontinued operations | - | 0 | 0 | 0 |
| Net cash used in operating activities | -40,366 | 60,678 | 14,317 | -37,211 |
| Proceeds from the sale and maturity of marketable debt securities | 48,782 | 82,420 | 106,622 | 134,553 |
| Purchase of fixed assets | - | - | 140 | 235 |
| Purchase of marketable debt securities | 5,055 | 167,925 | 4,846 | 64,371 |
| Purchase of intangible assets | 22,178 | 19,239 | 15,048 | 23,870 |
| Payment of milestone | - | 0 | 0 | 0 |
| Other | 0 | 470 | -3 | -63 |
| Net cash provided by (used in) investing activities - continuing operations | - | 27,892 | - | - |
| Net cash provided by investing activities - discontinued operations | - | 0 | - | - |
| Net cash provided by investing activities | 21,549 | -104,839 | 86,591 | 46,140 |
| Payment of guaranteed minimum royalty | 525 | 525 | 525 | 1,050 |
| Repayment of 2025 convertible senior notes | - | 0 | 68,904 | - |
| Proceeds from the issuances under the employee stock purchase plan | - | 1,255 | 0 | 1,537 |
| Proceeds from the issuance of common stock, net of issuance costs | - | 0 | - | - |
| Net cash (used in) provided by financing activities - continuing operations | - | -33,467 | - | - |
| Proceeds from the issuance of pre-funded warrants, net of issuance costs | - | 0 | - | - |
| Net cash used in financing activities - discontinued operations | - | 0 | - | - |
| Proceeds from exercise of stock options | 4,729 | 25,949 | 4,090 | 4,706 |
| Net cash provided by financing activities | 4,204 | 26,679 | -65,339 | 5,193 |
| Effect of exchange rate changes on cash | -60 | -413 | 207 | 2,497 |
| Net (decrease) increase in cash and cash equivalents | -14,673 | -17,895 | 35,776 | 16,619 |
| Cash and cash equivalents, beginning of year | 93,035 | 110,930 | 58,535 | - |
| Cash and cash equivalents, end of period | 78,362 | 93,035 | 110,930 | - |